Twist Bioscience, Broad Institute partner

By The Science Advisory Board staff writers

October 13, 2021 -- Twist Bioscience and the Broad Institute have created a custom next-generation sequencing (NGS) target enrichment exome panel to be used to research cancer and rare and inherited disease genes.

Twist will market the exome panel as the Twist Alliance Clinical Research Exome. The offering will help support the Broad Institute's genomics platform and was designed using validated data from clinical patient samples, Twist said.

The panel leverages Twist's NGS platform to customize content, resulting in a comprehensive survey of the exome with supplemental enrichment of clinically relevant areas of the genome related to cancer and rare and inherited diseases. By leveraging the uniformity of Twist NGS probes, the assay enables a per sample cost and throughput efficiency that Broad has already leveraged to process more than 250,000 samples to date.

Twist, Centogene to develop rare disease assay kits
Twist Bioscience and Centogene have signed a contract to collaborate on the development and commercialization of custom assay kits for rare diseases.
Twist Bioscience expands Alliance Panel
Twist Bioscience has expanded its Alliance Panel offering to include products designed by expert collaborators that have a wide range of clinical applications.
Twist, DeepCDR collaborate on antibody libraries
Twist Bioscience announced it is collaborating with DeepCDR to apply deep-learning algorithms to Twist's antibody discovery and optimization capabilities.
Twist inks collaboration deal with Adicet Bio
Twist Bioscience and Adicet Bio will collaborate on the discovery and development of gamma delta T-cell cancer therapies.
Boehringer, Twist to collaborate on antibody discovery
Boehringer Ingelheim and Twist Bioscience have entered a research collaboration to discover therapeutic antibodies against multiple targets.

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter